-
Announcement of the National Medical Products Administration, the National Health Commission and the National Healthcare Security Administration on Effectively Implementing Unique Device Identification for Subsequent Medical Device Products (No. 21, 2026)
2026-10-27
To further implement the Regulations for the Supervision and Administration of Medical Devices, the Opinions of the General Office of the State Council on Comprehensively Deepening the Reform of Regulation of Drugs and Medical Devices to Promote the High-Quality Development of the Pharmaceutical Industry, and the relevant key tasks of the State Council on deepening the reform of the medical and health system, and, on the basis of implementing Unique Device Identification (UDI) for all Class III medical devices (including in vitro diagnostic reagents) and 103 Class II medical device products, the relevant work on implementing UDI for subsequent medical device products is hereby announced as follows.
-
Announcement of the National Medical Products Administration on Strengthening Supervision and Administration of Contract Manufacturing of Drugs (No. 134, 2025)
2026-04-14
In order to further strengthen supervision and administration of contract manufacturing of marketed drugs, clarify the obligations and responsibilities of all parties, and urge the marketing authorization holders (hereinafter referred to as MAHs) for marketed drugs under contract manufacturing and contract manufacturers to jointly fulfill the main responsibility of ensuring drug quality and safety, the relevant matters concerning strengthening supervision and administration of drug contract manufacturing are hereby announced in accordance with the Drug Administration Law of the People's Republic of China and the Provisions for the Supervision and Administration of Drug Manufacturing.
-
Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
2025-12-24
In order to implement the spirit of "Supporting the Export Trade of Drugs and Medical Devices" outlined in the Opinions of the General Office of the State Council on Comprehensively Deepening the Reform of the Regulation of Drugs and Medical Devices to Promote the High-Quality Development of the Pharmaceutical Industry (GBF [2024] No. 53), the National Medical Products Administration (NMPA) has formulated the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers, (hereinafter referred to as the "Provisions").
-
Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
2025-12-24
In order to support the export trade of pharmaceutical products and strengthen the management of inspection and export certificate for exported pharmaceutical products of pharmaceutical manufacturers, the National Medical Products Administration has formulated the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers, which is hereby promulgated and shall come into force as of January 1, 2026.
-
Revision and Release of the Good Manufacturing Practice for Medical Devices
2025-12-24
On November 4, the National Medical Products Administration (NMPA) released the revised version of the Good Manufacturing Practice for Medical Devices (hereinafter referred to as the GMP). The new GMP for medical devices shall come into effect as of November 1, 2026.
-
Requirements for the Pilot Program of Electronic Labels for Cosmetics
2025-12-24
To regulate the pilot program for electronic labels for cosmetics (including toothpaste, hereinafter referred to as "cosmetics"), these Requirements are formulated in accordance with the provisions of the Regulations on Supervision and Administration of Cosmetics (hereinafter referred to as the "Regulations"), the Provisions for Registration and Filing of Cosmetics, the Provisions for Supervision and Administration of Manufacturing and Marketing of Cosmetics, the Provisions for Toothpaste Regulation, and the Measures for the Administration of Cosmetics Labels.
